A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX). Results of the 12-month ...
Jan 24, 2013
0
0
Using a hand held device the size of a computer mouse for just 30 minutes could significantly change how people deal with, and recover from, the pain associated with musculoskeletal conditions.
Sep 7, 2012
0
0
In what could be a breakthrough in the practical application of epigenetic science, U.K. scientists used human tissue samples to discover that those with osteoarthritis have a signature epigenetic change (DNA methylation) ...
Jul 6, 2012
0
0
Craig Hutto considers himself part bionic man. In 2005, doctors amputated his leg after a shark attacked him during a fishing trip off the Florida Gulf Coast.
Jan 24, 2012
0
0
A new genomics study, led by the Center for Applied Genomics at The Children's Hospital of Philadelphia, sets the stage for the first predictive diagnostic test in a serious immunodeficiency disease in children. If the disorder, ...
May 11, 2011
0
0
Crowdsourcing has become an increasingly popular way to develop machine learning algorithms to address many clinical problems in a variety of illnesses. Today at the American College of Rheumatology (ACR) annual meeting, ...
Nov 6, 2021
0
3
In a clinical trial of patients with rheumatoid arthritis, treatment with a drug called upadacitinib provided greater benefits than methotrexate, the most commonly used initial therapy for rheumatoid arthritis.
Jul 8, 2020
0
3
Degeneration of cartilage and other joint tissues is a major cause of disability. A new review highlights the recent developments in biofabrication, a new technique that allows investigators to print living tissues for implantation ...
Jun 26, 2017
0
0
The results of a large population study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed an increased risk of developing Psoriatic Arthritis (PsA) among psoriasis patients exposed ...
Jun 11, 2015
0
14
The results of the tREACH trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that initial therapy with combination DMARDs significantly improves measures of ...
Jun 10, 2015
0
5
